Detalhe da pesquisa
1.
Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.
Genet Med
; : 101171, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38828701
2.
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.
Gynecol Oncol
; 187: 198-203, 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795508
3.
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
Breast Cancer Res
; 25(1): 53, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37161532
4.
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.
Am J Hum Genet
; 107(5): 837-848, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022221
5.
Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
Am J Obstet Gynecol
; 228(4): 440.e1-440.e20, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403862
6.
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.
BJOG
; 130(8): 968-977, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715559
7.
Common variants in breast cancer risk loci predispose to distinct tumor subtypes.
Breast Cancer Res
; 24(1): 2, 2022 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983606
8.
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Genet Med
; 23(9): 1726-1737, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34113011
9.
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
Br J Cancer
; 121(2): 180-192, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31213659
10.
Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.
Mod Pathol
; 30(1): 15-25, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27612322
11.
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
PLoS Biol
; 9(11): e1001199, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22110403
12.
The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families.
Breast
; 73: 103611, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039887
13.
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
PLoS Genet
; 6(10): e1001183, 2010 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21060860
14.
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Hum Mutat
; 33(4): 690-702, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22253144
15.
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.
Breast Cancer Res
; 14(1): R33, 2012 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22348646
16.
The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.
Cancer
; 118(4): 899-907, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21761396
17.
Breast cancer risks associated with missense variants in breast cancer susceptibility genes.
Genome Med
; 14(1): 51, 2022 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585550
18.
Rare germline copy number variants (CNVs) and breast cancer risk.
Commun Biol
; 5(1): 65, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042965
19.
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Hum Genet
; 130(5): 685-99, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21597964
20.
Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.
Breast Cancer Res Treat
; 128(1): 79-84, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20676756